Movement Disorders · 2007 · 289 citations · 19 references
MedicineNeurologyNeuroscienceMovement DisordersNeuromuscular DisordersNeuropathologyMotor DisordersNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersAssociated Neurological SymptomsClinical Diagnosis Of ParkinsonismDifferential Diagnosis Of ParkinsonismMann - Whitney U TestMisdiagnosis DetectionNeurodegenerative Disease Symptom BurdenNeurological EtiologyProdromal Parkinson's Disease
Nonmotor symptoms are increasingly recognized as a major source of morbidity in Parkinson’s disease, yet their prevalence as initial presenting complaints in pathologically confirmed cases remains unknown. The study examined the presenting complaints of 433 pathologically confirmed Parkinson’s disease cases from the Queen Square Brain Bank by reviewing clinical case notes. Among these patients, 21 % presented with nonmotor symptoms—most commonly pain (15 %), urinary dysfunction (3.9 %) and anxiety or depression (2.5 %)—and such presentations were linked to delayed diagnosis, higher rates of misdiagnosis and referral to non‑neurologists, potentially inappropriate interventions, but did not alter motor response to medication and were associated with a shorter disease duration.
Nonmotor symptoms (NMS) are increasingly recognized as a significant cause of morbidity in later stages of Parkinson's disease (PD). Prodromal NMS are also a well recognized component of the clinical picture in some patients but the prevalence of NMS as presenting complaints, and their impact on clinical management, in pathologically-proven cases of PD is unknown. The presenting complaints of 433 cases of pathologically-proven PD archived at the Queen Square Brain Bank for Neurological Diseases were identified from the clinical case notes. 91/433 (21%) of patients with PD presented with NMS of which the most frequent were pain (15%), urinary dysfunction (3.9%), anxiety, or depression (2.5%). Presenting with NMS is associated with a delayed diagnosis of PD (Mann-Whitney U, P = 0.001). These patients were more likely to be misdiagnosed initially and were more likely to have been referred to orthopedic surgeons or rheumatologists than neurologists (nonmotor group 5.5% vs. motor group 44.2%, chi(2) P < 0.0001). NMS are commonly seen as presenting complaints in pathologically confirmed PD, and initial misdiagnosis may be associated with potentially inappropriate medical interventions. Presenting with NMS does not affect the motor response to medication, but is associated with shorter disease duration (chi(2) P = 0.016).
19
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Julian Fearnley, Andrew J. Lees · Brain · 1991 · 3.5K citations
James Parkinson · Journal of Neuropsychiatry · 2002 · 1.3K citations · Full text
Medicine, Neurology, Psychiatry +8
К. Ray Chaudhuri, Pablo Martínez‐Martín, Anthony H.V. Schapira et al. · Movement Disorders · 2006 · 1.1K citations